Sentence: Longer progression-free survival ( PFS ) and overall survival ( OS ) were observed with T-DM1 compared with capecitabine plus lapatinib in all biomarker subgroups .
Drug combination annotation:
[{'class': 'COMB', 'spans': ['capecitabine', 'lapatinib'], 'is_context_needed': True}]